Number of noninvasive technology board monitors shipped (units)

Percentage decrease in noninvasive technology board monitors shipped year-on-year (percentage)

a60bf0aff93f7b2a95982b28e0a6ef77d4b5b0f3bc5c31ab4411f3eb9e359a5c

Cash and cash equivalents (USD, millions)

Trade accounts receivable, net of allowance for credit losses (USD, millions)

Related party receivables - (Note 3) (USD, millions)

Inventories (USD, millions)

Asset held for sale (USD, millions)

Other current assets (USD, millions)

Total current assets (USD, millions)

Lease receivable, non-current (USD, millions)

Deferred costs and other contract assets (USD, millions)

Property and equipment, net (USD, millions)

Customer relationships, net - (Note 9) (USD, millions)

Acquired technologies, net - (Note 9) (USD, millions)

Other intangible assets, net (USD, millions)

Trademarks - (Note 9) (USD, millions)

Goodwill (USD, millions)

Deferred tax assets (USD, millions)

Other non-current assets (USD, millions)

Total assets (USD, millions)

Accounts payable (USD, millions)

Accrued compensation (USD, millions)

Deferred revenue and other contract-related liabilities, current (USD, millions)

Other current liabilities (USD, millions)

Total current liabilities (USD, millions)

Long-term debt (USD, millions)

Deferred tax liabilities (USD, millions)

Other non-current liabilities (USD, millions)

Total liabilities (USD, millions)

Common stock, $ 0.001 par value; 100.0 shares authorized; shares issued and outstanding (USD, millions)

Treasury stock, shares at December 28, 2024 and December 30, 2023, respectively (USD, millions)

Additional paid-in capital (USD, millions)

Accumulated other comprehensive loss (USD, millions)

Retained earnings (USD, millions)

Total stockholders’ equity (USD, millions)

Total liabilities and stockholders’ equity (USD, millions)

1d710d2aa435640e1d7da344d93a8ab1c15b6a6bbe19e1f5fb1baf89a5cc1392

Product Revenue (USD, millions)

Related Party Revenue (USD, millions)

Total Revenue (USD, millions)

Cost of Goods Sold (USD, millions)

Gross Profit (USD, millions)

Selling, General and Administrative Expenses (USD, millions)

Research and Development Expenses (USD, millions)

Litigation Settlements (USD, millions)

Impairment Charges, including Intangible Assets and Goodwill (USD, millions)

Impairment Charge (USD, millions)

Total Operating Expenses (USD, millions)

Operating (Loss) Income (USD, millions)

Non-Operating Loss (USD, millions)

(Loss) Income before Provision for Income Taxes (USD, millions)

(Benefit) Provision for Income Taxes (USD, millions)

Net (Loss) Income (USD, millions)

b0290fda2123d050dd09c071ce3996ba451c61d7b92c675506cca37fb870008a

United States

Europe, Middle East, Africa

Asia and Australia

North and South America

Total Revenue

af4bd6fc31c05e2f08c1f21a8cb33d3f752c377a593b1c5c3b09086729917425

63e6a70da1712fc99caa5fb7be80c78ca602b98df769ca895c8e1202c3cc430d

Healthcare

- Direct Sales

- OEM Channel

Non-healthcare

53b8844a5a1bef09c8b19b25e0ce46d6065dad04527eefcb22d9ff3d9d46dfb8

MASIMO (MASI)

Financials